skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 93  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Inflammatory and Cholesterol Risk in the FOURIER Trial
Material Type:
Article
Add to My Research

Inflammatory and Cholesterol Risk in the FOURIER Trial

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.131-140 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034032 ;PMID: 29530884

Full text available

2
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Material Type:
Article
Add to My Research

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.911-921 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 28, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.11.070 ;PMID: 28231942

Full text available

3
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome
Material Type:
Article
Add to My Research

Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome

Clinical chemistry (Baltimore, Md.), 2014-01, Vol.60 (1), p.158-164 [Peer Reviewed Journal]

COPYRIGHT 2014 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jan 2014 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2013.206441 ;PMID: 24052087

Full text available

4
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system
Material Type:
Article
Add to My Research

Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system

EClinicalMedicine, 2020-09, Vol.26, p.100504-100504, Article 100504 [Peer Reviewed Journal]

2020 The Authors ;2020 The Authors. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020 The Authors 2020 ;ISSN: 2589-5370 ;EISSN: 2589-5370 ;DOI: 10.1016/j.eclinm.2020.100504 ;PMID: 32838244

Digital Resources/Online E-Resources

5
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry
Material Type:
Article
Add to My Research

Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry

Journal of the American Heart Association, 2022-05, Vol.11 (9), p.e024451-e024451 [Peer Reviewed Journal]

2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.121.024451 ;PMID: 35470683

Full text available

6
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2017-10, Vol.390 (10105), p.1833-1842 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 21, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32247-X ;PMID: 28855077

Full text available

7
The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript
Material Type:
Article
Add to My Research

The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript

The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15991-15997 [Peer Reviewed Journal]

2003 © 2003 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M300714200 ;PMID: 12604614

Full text available

8
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician
Material Type:
Article
Add to My Research

Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician

Circulation (New York, N.Y.), 2019-12, Vol.140 (24), p.2019-2037 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.034512

Full text available

9
COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
Material Type:
Article
Add to My Research

COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

JACC. Basic to translational science, 2020-05, Vol.5 (5), p.518-536 [Peer Reviewed Journal]

2020 Published by Elsevier on behalf of the American College of Cardiology Foundation. 2020 ;EISSN: 2452-302X ;DOI: 10.1016/j.jacbts.2020.04.002 ;PMID: 32292848

Full text available

10
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2016-07, Vol.134 (1), p.24-36 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022361 ;PMID: 27358434

Full text available

11
A current review of COVID-19 for the cardiovascular specialist
Material Type:
Article
Add to My Research

A current review of COVID-19 for the cardiovascular specialist

The American heart journal, 2020-08, Vol.226, p.29-44 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.04.025 ;PMID: 32497913

Full text available

12
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
Material Type:
Article
Add to My Research

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome

Journal of the American College of Cardiology, 2016-02, Vol.67 (4), p.353-361 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright Elsevier Limited Feb 2, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.10.077

Full text available

13
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT
Material Type:
Article
Add to My Research

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT

Circulation (New York, N.Y.), 2015-09, Vol.132 (13), p.1224-1233 [Peer Reviewed Journal]

2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.115.018381 ;PMID: 26330412

Full text available

14
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
Material Type:
Article
Add to My Research

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke (1970), 2020-05, Vol.51 (5), p.1546-1554 [Peer Reviewed Journal]

2020 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.119.027759 ;PMID: 32312223

Full text available

15
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
Material Type:
Article
Add to My Research

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Circulation (New York, N.Y.), 2022-01, Vol.145 (4), p.242-255 [Peer Reviewed Journal]

ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056355 ;PMID: 34985309

Full text available

16
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Material Type:
Article
Add to My Research

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Circulation (New York, N.Y.), 2018-04, Vol.137 (15), p.1571-1582 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.030950 ;PMID: 29263150

Full text available

17
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT
Material Type:
Article
Add to My Research

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2440-2450 [Peer Reviewed Journal]

2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.029095 ;PMID: 28972004

Full text available

18
Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel
Material Type:
Article
Add to My Research

Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel

Journal of the American College of Cardiology, 2020-09, Vol.76 (11), p.1345-1357 [Peer Reviewed Journal]

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.06.080 ;PMID: 32710927

Full text available

19
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article
Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

20
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
Material Type:
Article
Add to My Research

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

Circulation (New York, N.Y.), 2016-07, Vol.134 (4), p.304-313 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.115.019861 ;PMID: 27440003

Full text available

Results 1 - 20 of 93  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (83)

Refine My Results

Creation Date 

From To
  1. Before 2014  (3)
  2. 2014 To 2015  (6)
  3. 2016 To 2017  (14)
  4. 2018 To 2020  (43)
  5. After 2020  (28)
  6. More options open sub menu

Searching Remote Databases, Please Wait